Captura de pantalla 2023-11-10 082355 big.png
Lipella Pharmaceuticals to Participate at H.C. Wainwright's 26th Annual Global Investment Conference in New York
August 27, 2024 08:00 ET | Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals to Participate at H.C. Wainwright's 26th Annual Global Investment Conference in New York
Logo.png
Halberd Corp. Issues Letter to Shareholders
August 26, 2024 08:00 ET | Halberd Corp.
Halberd Corp. - Taking a Moment to Recenter Our Technical Progress
ANEW MEDICAL, INC. Achieves Debt-Free Status, Boosts Financial Flexibility
August 26, 2024 05:00 ET | ANEW MEDICAL, INC.
ANEW MEDICAL, INC. Achieves Debt-Free Status, Boosts Financial Flexibility
Captura de pantalla 2023-11-10 082355 big.png
Lipella Pharmaceuticals Unveils Advanced Bladder Imaging Technique at ICICJ Conference
August 21, 2024 05:00 ET | Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Unveils Advanced Bladder Imaging Technique at ICICJ Conference
PMV main logo.png
PRISM MarketView Features Oncocyte CFO Andrea S. James on Her Career and Leadership in Molecular Diagnostics Technology
August 20, 2024 09:00 ET | PRISM MarketView
PRISM MarketView Features Oncocyte CFO Andrea S. James on Her Career and Leadership in Molecular Diagnostics Technology
ANEW MEDICAL, INC. Appoints New CFO
August 19, 2024 05:00 ET | ANEW MEDICAL, INC.
ANEW MEDICAL, INC. Appoints New CFO
Dr. Yen-Michael Hsu
Gift of Life Marrow Registry Names Dr. Yen-Michael Hsu as Co-Chief Medical Officer
August 13, 2024 11:47 ET | Gift of Life Marrow Registry
BOCA RATON, Fla., Aug. 13, 2024 (GLOBE NEWSWIRE) -- Gift of Life Marrow Registry today announced the appointment of Yen-Michael Hsu, M.D., Ph.D., MBA, CABP as Co-Chief Medical Officer. Dr. Hsu's...
Captura de pantalla 2023-11-10 082355 big.png
Lipella Pharmaceuticals Doses First Two Patients in Phase 2a Oral Lichen Planus Clinical Trial
August 12, 2024 05:00 ET | Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Doses First Two Patients in Phase 2a Oral Lichen Planus Clinical Trial
ANEW MEDICAL, INC. Pursues Neurological Approach to Treating Weight Loss and Eating Disorders through Melanocortin Receptor Binding Peptides
August 09, 2024 05:00 ET | ANEW MEDICAL, INC.
ANEW MEDICAL, INC. Pursues Neurological Approach to Treating Weight Loss and Eating Disorders through Melanocortin Receptor Binding Peptides
ANEW MEDICAL, INC. Announces Patents Issued in Major Asian Markets for use of Genetic Therapy in the Treatment of Alzheimer’s Disease and ALS
August 08, 2024 05:00 ET | ANEW MEDICAL, INC.
ANEW MEDICAL, INC. Announces Patents Issued in Major Asian Markets for use of Genetic Therapy in the Treatment of Alzheimer’s Disease and ALS